Doç. Dr. Özge Vural Topuz

• Prostat neoplazmları 2 yayın
  Kaynak: OpenAlex / PubMed MeSHYayınları gör

Hekimin kurum profilinde kendi belirttiği tıbbi ilgi alanları. Kaynak: acibadem.com.tr.

Deneyim

• 2024Acıbadem Sağlık Grubuacibadem.com.tr
• 2024Sağlık Bilimleri Üniversitesi, Hamidiye Tıp Fakültesi Nükleer Tıp Anabilim Dalıacibadem.com.tr
• 2020 - 2024TC Sağlık Bakanlığı Çam ve Sakura Şehir Hastanesiacibadem.com.tr
• 2011 - 2020SBÜ Okmeydanı EAH /Nükleer Tıp uzmanıacibadem.com.tr

Eğitim

• 2011İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Nükleer Tıp, Uzmanlıkacibadem.com.tr
• 2006İstanbul Bilim Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

• UzmanlıkNükleer Tıpacibadem.com.trKaynaktan
• KurumAcıbadem Maslak Hastanesiacibadem.com.trKaynaktan
• Çalıştığı konuProstat neoplazmları2 yayından çıkarıldı · Model sürümü —Kaynaktan
• Yayınlar30 yayınOpenAlexKaynaktan
• Son eşitleme4 Kasım 2026 21:05https://www.acibadem.com.tr/doktor/ozge-vural-topuz/acibadem.com.tr

1. Physiological differences in bone uptake of [99mTc]Tc-pyrophosphate in men and women undergoing cardiac scintigraphy

   Journal of Nuclear Cardiology, 2026

   DOI 10.1016/j.nuclcard.2026.102654 PMID 41655808 1 atıf (Europe PMC) Kaynak: OpenAlex

2. Assessment of changes in physiologic distribution of 68Ga-PSMA in normal tissues relative to tumor burden in patients undergoing PET/CT for prostate cancer

   Çukurova medical journal (Online)/Çukurova medical journal, 2026

   DOI 10.17826/cumj.1858822 Kaynak: OpenAlex

3. Diuretic-Enhanced Dual-Phase F-18 FDG PET/CT: A New Window Into Muscle-Invasive Bladder Cancer

   World Journal of Nuclear Medicine, 2026

   DOI 10.1055/s-0046-1824462 PMID 42788180 Açık erişimli tam metinKaynak: OpenAlex

4. Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer

   Nuklearmedizin - NuclearMedicine, 2025

   DOI 10.1055/a-2512-8212 PMID 39875129 2 atıf (Europe PMC) Kaynak: OpenAlex

5. Tumoricidal dosing approach with parenchymal sparing using voxel-based dosimetry in 90Y glass microspheres treatment of hepatocellular carcinoma

   Nuclear Medicine Communications, 2025

   DOI 10.1097/mnm.0000000000001991 PMID 40341049 Kaynak: OpenAlex

6. Predicción de la respuesta completa a la quimiorradioterapia neoadyuvante en el cáncer de recto localmente avanzado: papel de los parámetros volumétricos basales de la PET/TC con [18F]FDG y los marcadores inflamatorios

   Revista Española de Medicina Nuclear e Imagen Molecular, 2025

   DOI 10.1016/j.remn.2025.500113 1 atıf (OpenAlex) Kaynak: OpenAlex

7. Relation Between Primary Tumor Suvmax Value, Ki-67 Proliferation Index and Axillary Metastasis in Patients with Triple Negative Breast Cancer

   Bagcilar Medical Bulletin, 2025

   DOI 10.4274/bmb.galenos.2025.69885 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

8. Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: The role of baseline volumetric 18F-FDG PET/CT parameters and inflammatory markers

   Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2025

   DOI 10.1016/j.remnie.2025.500113 PMID 39921167 2 atıf (Europe PMC) Kaynak: OpenAlex

9. Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT

   Nuklearmedizin - NuclearMedicine, 2024

   DOI 10.1055/a-2224-9673 PMID 38190994 3 atıf (Europe PMC) Kaynak: OpenAlex

10. Can post neoadjuvant chemotherapy 18F-FDG PET/CT predict residual cancer burden in locally advanced breast cancer?

    Médecine Nucléaire, 2024

    DOI 10.1016/j.mednuc.2024.03.001 1 atıf (OpenAlex) Kaynak: OpenAlex